Summary by Moomoo AI
John C Jacobs, President and CEO of Novavax Inc. (NVAX), was reported to have engaged in a transaction involving the company's stock on March 1, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of the shares, were not disclosed in the announcement. The report did not provide information on the number of shares held by Jacobs after the action.